ArticleBMC cardiovascular disorders2025
Association between elevated glycosylated hemoglobin levels and hypertension among US adults: NHANES 2011-2018.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Longitudinal trajectories and predictors of glycated hemoglobin among type 2 diabetes patients concomitant with hypertension: spline based linear mixed-effects model.Scientific reports · 2026Article
- Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults.Hypertension (Dallas, Tex. : 1979) · 2025Article
- The impact of glycated hemoglobin trajectories on hypertension risk: a retrospective cohort study.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHypertension (HTN) and diabetes frequently coexist. This study aims to elucidate the associations between HTN and glycosylated hemoglobin (HbA1c), as well as the connections between distinct forms of HTN and HbA1c.
methodsWe collected data from National Health and Nutrition Examination Survey (NHANES) 2011-2018 in this study, including anthropometric tests and biochemical measures. The HbA1c levels were grouped by participants with diabetes, prediabetes, or no diabetes. Correlations between HbA1c and HTN, isolated systolic hypertension (ISH), and isolated diastolic hypertension (IDH) risk were investigated by logistic analyses. A fitting curve has drown to describe the association between HTN and HbA1c.
resultsAmong the 10,503 enrolled participants, The prevalence of HTN notably increased with higher HbA1c levels (P < 0.001). In the adjusted model, compared to the lowest HbA1c group, the odds ratio (OR) with its 95% confidence interval (CI) was 1.22 (1.07 ~ 1.39) for the highest HbA1c group. There was a significant increase in the risk of ISH with higher HbA1c levels in group 3 compared to group 1 (OR: 1.3, 95% CI: 1.1 ~ 1.53).The adjusted model revealed no significant association between HbA1c levels and the risk of IDH.
conclusionThere is a independent influence of HbA1c on HTN risk in adults in the United States. Notably, the risk of developing HTN increases most rapidly when HbA1c levels approach 5.5%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.